BRAINTREE, Mass. (AP) _ Haemonetics Corp. (HAE) on Tuesday reported a fiscal first-quarter loss of $2.8 million, after reporting a profit in the same period a year earlier.

On a per-share basis, the Braintree, Massachusetts-based company said it had a loss of 5 cents. Earnings, adjusted for one-time gains and costs, were 59 cents per share.

The results surpassed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of 42 cents per share.

The provider blood management systems for health care providers and blood collectors posted revenue of $229.3 million in the period, also beating Street forecasts. Four analysts surveyed by Zacks expected $219.5 million.

Haemonetics expects full-year earnings in the range of $2 to $2.30 per share.

Haemonetics shares have risen 67 percent since the beginning of the year. The stock has more than doubled in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on HAE at https://www.zacks.com/ap/HAE